GC Biopharma reported third-quarter operating profit of 49.2 billion won ($36.8 million) on a consolidated basis, up 68.5 percent from a year earlier, the company disclosed Monday.
Revenue for the same period fell 14.3 percent to 522.1 billion won.
Net profit for the period came in at 208.5 billion won, a preliminary figure representing a 1,051.9 percent increase.
jiyoon436@heraldcorp.com
